13F

Stock

Protalix BioTherapeutics, Inc.

PLX · held by 4 managers

Reported value

$450.8K

Holders

4

+0 new · −0 exited

Holders’ est. mark

$75.3K

Price effect on 1 books still in the name

Largest holder

$226K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC101.8K$226K$75.3KAdded$38.1K
MORGAN STANLEY71K$157.7KHeld
BANK OF AMERICA CORP /DE/20.1K$44.7KHeld
HARBOUR INVESTMENT MANAGEMENT LLC10.1K$22.4KHeld

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.